Debut Plus

239.5

+1 +0.42%

17 Jul 2026

NSE Listed

Medicamen Biotech Limited (MEDICAMEQ)

Volume: 9,298Avg Vol 1W: 12,730.4Avg Vol 1M: 35,482.0552W Range:212.4447.65
Key Ratios
Checked 6h ago
Market Cap₹326 Cr
Current Price₹239.5
Previous Close₹238.5
High / Low (52w)₹447.65 / ₹212.4
Volume9,298
Avg Vol (1W)12,730.4
Avg Vol (1M)35,482.05
Stock P/E73.2
Book Value₹203.17
Dividend Yield42%
ROE349.9%
ROA263.2%
Revenue (TTM)₹169 Cr
Revenue Growth-9.3%
Profit Margin5.5%
Total Debt₹4 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹7.11
P/B1.18
Debt / Equity0.15
50 DMA₹248.55
200 DMA₹311.01
Day change+0.42%
Price Chart
239.5 42.04% · 1Y
4162233.3L
2025-07-17
2026-07-16

20-day avg volume: 35K shares

Pros
  • Healthy return on equity of 349.9%.
  • Pays a dividend yield of 42.0%.
  • Company is almost debt-free.
  • Revenue grew 12% YoY.
Cons
  • Stock trades at a high P/E of 73.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹43 Cr₹45 Cr₹45 Cr₹30 Cr₹43 Cr₹47 Cr₹47 Cr₹61 Cr
EBITDA₹2 Cr₹3 Cr₹5 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹5 Cr
Net Profit₹1 Cr₹1 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹4 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹127 Cr₹113 Cr₹117 Cr₹143 Cr₹182 Cr₹169 Cr
EBITDA₹19 Cr₹17 Cr₹20 Cr₹20 Cr₹17 Cr₹13 Cr
Net Profit₹13 Cr₹12 Cr₹15 Cr₹15 Cr₹11 Cr₹7 Cr
EPS
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹181 Cr₹194 Cr₹226 Cr₹279 Cr₹295 Cr₹297 Cr
Total Liabilities₹60 Cr₹61 Cr₹79 Cr₹85 Cr₹88 Cr₹84 Cr
Equity₹121 Cr₹133 Cr₹146 Cr₹193 Cr₹207 Cr₹213 Cr
Total Debt₹2 Cr₹6 Cr₹5 Cr₹1 Cr₹1 Cr₹4 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹17 Cr₹17 Cr₹7 Cr₹-3 Cr₹-4 Cr₹-7 Cr
Investing₹-37 Cr₹-18 Cr₹-8 Cr₹-6 Cr₹-6 Cr₹-1 Cr
Financing₹19 Cr₹6 Cr₹4 Cr₹29 Cr₹6 Cr₹-1 Cr
Free Cash Flow₹17 Cr₹17 Cr₹7 Cr₹-3 Cr₹-4 Cr₹-7 Cr
Shareholding
Promoter 62.97% Institutions 0% Public 37.03%
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search